Catalent Stock Forecast for 2023 - 2025 - 2030

Updated on 05/27/2024

Stock Rating
15
Price Target
$63.50
Consensus
Neutral
Upside
15.83%
Analysts
3
Stock Rating
15
Upside
15.83%
Analysts
3
Price Target
$63.50

Catalent Stock Forecast and Price Target

The average price target of $63.50 for Catalent's stock set by three distinguished analysts in recent weeks would represent a potential upside of approximately 15.83% from the last closing price in May, 2024 if reached by the end of the year. This potential increase is based on a high estimate of $63.50 and a low estimate of $63.50. Even if you are not interested in CTLT stock, it is still imperative to be aware of its competitors.

$63.50

15.83% Upside

Hold
Hold

Catalent Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Catalent has seen a decline in its Price, from $68.26 to $0.00 – a 100.00% decrease. In the next year, analysts believe that Fair Value will reach $24.59 – an increase of 100.00%. For the next nine years, the forecast is for Fair Value to grow by 100.00%.

2024 Fair Value Forecast
$24.59
2025 Fair Value Forecast
$56.29
2025 Fair Value Forecast
$56.29
2026 Fair Value Forecast
$69.88
2026 Fair Value Forecast
$69.88
2027 Fair Value Forecast
$87.99
2028 Fair Value Forecast
$111.93
2029 Fair Value Forecast
$131.66
2030 Fair Value Forecast
$155.60
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
TMO Stock Forecast Thermo Fisher Scientific Outperform 10
$584.05 Buy/Sell $591.94 6.16%
ABT Stock Forecast Abbott Laboratories Outperform 9
$103.95 Buy/Sell $118.92 20.25%
IQV Stock Forecast IQVIA Holdings Outperform 15
$229.60 Buy/Sell $267.27 19.77%
LONN Stock Forecast Lonza Group Buy 16
CHF512.80 Buy/Sell CHF516.89 17.00%
A207940 Stock Forecast Samsung Biologics Buy 7
₩755.00k Buy/Sell ₩0.00B 35.76%

Catalent Revenue Forecast for 2023 - 2025 - 2030

Catalent's Revenue has seen impressive growth In the last three years, rising from $3.09B to $4.26B – a growth of 37.78%. In the next year, analysts believe that Revenue will reach $4.36B – an increase of 2.21%. For the next nine years, the forecast is for Revenue to grow by 52.01%.

2024 Rev Forecast
$4.36B
2025 Rev Forecast
$4.65B
2025 Rev Forecast
$4.65B
2026 Rev Forecast
$4.95B
2026 Rev Forecast
$4.95B
2027 Rev Forecast
$5.17B
2028 Rev Forecast
$5.35B
2029 Rev Forecast
$5.87B
2030 Rev Forecast
$6.48B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ICLR Stock Forecast ICON Public Buy 16
$320.72 Buy/Sell $306.07 12.25%
LH Stock Forecast Laboratory Corp of America Hol... Outperform 11
$199.65 Buy/Sell $241.28 21.21%
603259 Stock Forecast WuXi AppTec Buy 18
¥42.42 Buy/Sell ¥121.48 49.41%

Catalent Dividend per Share Forecast for 2023 - 2025 - 2030

2024 DPS Forecast
$0.00
2025 DPS Forecast
$0.00
2026 DPS Forecast
$0.00
2026 DPS Forecast
$0.00
2027 DPS Forecast
$0.00
2028 DPS Forecast
$0.00
2029 DPS Forecast
$0.00
2030 DPS Forecast
$0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
DGX Stock Forecast Quest Diagnostics Outperform 10
$141.28 Buy/Sell $141.17 2.63%
VTRS Stock Forecast Viatris Inc Hold 8
$10.41 Buy/Sell $11.73 15.27%
DIVISLAB Stock Forecast Divi's Laboratories Hold 18
Rp4.26k Buy/Sell Rp3.30k -10.70%

Catalent Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$0.07B
2025 FCF Forecast
$0.17B
2025 FCF Forecast
$0.17B
2026 FCF Forecast
$0.27B
2027 FCF Forecast
$0.30B
2028 FCF Forecast
$0.43B
2029 FCF Forecast
$0.57B
2030 FCF Forecast
$0.70B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ERF Stock Forecast Eurofins Scientific Hold 18
57.20€ Buy/Sell 0.00€ 4.90%
CRL Stock Forecast Charles River Laboratories Int... Outperform 16
$217.21 Buy/Sell $229.97 24.30%
500124 Stock Forecast Dr. Reddy's Laboratories Hold 18
Rp5.88k Buy/Sell Rp5.67k 2.82%

Catalent EBITDA Forecast for 2023 - 2025 - 2030

Catalent's EBITDA has decreased In the last three years, from $660.00M to $629.00M – a 4.70% drop. Analysts predict that Catalent's EBITDA will increase in the upcoming year, reaching $719.15M. This would represent an increase of 14.33%. Over the next eight years, experts predict that Catalent's EBITDA will grow at a rate of 189.98%.

2024 EBITDA Forecast
$0.72B
2024 EBITDA Forecast
$0.72B
2025 EBITDA Forecast
$0.95B
2026 EBITDA Forecast
$1.13B
2027 EBITDA Forecast
$1.27B
2028 EBITDA Forecast
$1.43B
2029 EBITDA Forecast
$1.62B
2030 EBITDA Forecast
$1.82B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
DCC Stock Forecast DCC Buy 18
£57.10 Buy/Sell £67.24 22.94%
2269 Stock Forecast WuXi Biologics (Cayman) Outperform 8
HK$11.86 Buy/Sell HK$69.40 63.58%
300759 Stock Forecast Pharmaron Beijing Outperform 16
¥21.02 Buy/Sell ¥37.14 22.88%

Catalent EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Catalent's EBIT has seen a drop from $406.00M to $207.00M – a 49.01% decrease. In the next year, analysts believe that EBIT will reach $393.01M – an increase of 89.86%. For the next seven years, the forecast is forEBIT to grow by 477.33%.

2024 EBIT Forecast
$0.39B
2025 EBIT Forecast
$0.60B
2026 EBIT Forecast
$1.03B
2027 EBIT Forecast
$1.15B
2028 EBIT Forecast
$1.29B
2029 EBIT Forecast
$1.29B
2030 EBIT Forecast
$1.20B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
PRGO Stock Forecast Perrigo Co PLC Outperform 16
$27.88 Buy/Sell $44.75 43.47%
SFZN Stock Forecast Siegfried Holding Outperform 18
CHF886.00 Buy/Sell CHF891.22 16.31%
002821 Stock Forecast Asymchem Laboratories (Tianjin... Outperform 16
¥76.60 Buy/Sell ¥170.73 29.24%

Catalent EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Catalent has seen a decline in its EPS, from $2.11 to $0.00 – a 100.00% decrease. In the next year, analysts believe that EPS will reach $0.76 – an increase of 100.00%. For the next nine years, the forecast is for EPS to grow by 100.00%.

2024 EPS Forecast
$0.76
2025 EPS Forecast
$1.74
2025 EPS Forecast
$1.74
2026 EPS Forecast
$2.16
2026 EPS Forecast
$2.16
2027 EPS Forecast
$2.72
2028 EPS Forecast
$3.46
2029 EPS Forecast
$4.07
2030 EPS Forecast
$4.81
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
603456 Stock Forecast Zhejiang Jiuzhou Pharmaceutica... Buy 18
¥15.26 Buy/Sell ¥37.79 54.72%
EVT Stock Forecast Evotec Outperform 14
9.18€ Buy/Sell 37.33€ 74.29%
300363 Stock Forecast Porton Pharma Solutions Buy 18
¥15.33 Buy/Sell ¥37.00 73.84%